Literature DB >> 2235980

Reversal by antrectomy of endocrine cell hyperplasia in the gastric body in pernicious anemia: a morphometric study.

S E Kern1, J H Yardley, A J Lazenby, J K Boitnott, V W Yang, T M Bayless, J V Sitzmann.   

Abstract

Multifocal gastric carcinoid tumors occasionally develop in patients with pernicious anemia, associated with hyperplasia of endocrine cells in the atrophic and metaplastic gastric body mucosa. This constellation of findings probably requires a trophic drive from hypergastrinemia associated with antral G cell hyperplasia, a consequence of achlorhydria in these patients. We report a case in which antrectomy was performed on such a patient in order to abrogate the trophic stimulus. Antrectomy was followed by resolution of hypergastrinemia and a decrease in the size of polyps endoscopically. Nine months later, the gastric remnant was resected. Using morphometric techniques, endocrine cells in the initial antrectomy specimen (which included body mucosa at the resection line) were compared with those in the subsequently removed gastric body. Antrectomy resulted in striking decreases in number (137 versus 34/mm2; P = 0.0001) and size (93 versus 56 microns2; P = 0.0001) of endocrine cells of body mucosa. The findings suggest that antrectomy may be useful in the management of endocrine cell hyperplasia, and possibly also associated carcinoid tumors, in pernicious anemia.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2235980

Source DB:  PubMed          Journal:  Mod Pathol        ISSN: 0893-3952            Impact factor:   7.842


  11 in total

Review 1.  Hyperplastic proliferations of enteroendocrine cells.

Authors:  Yogeshwar Dayal
Journal:  Endocr Pathol       Date:  1994-03       Impact factor: 3.943

2.  Gastric carcinoid tumors.

Authors:  Russell Wardlaw; James W Smith
Journal:  Ochsner J       Date:  2008

Review 3.  [Therapy of carcinoids of the stomach].

Authors:  H D Becker; A Gabriel
Journal:  Langenbecks Arch Chir       Date:  1996

4.  Gastric carcinoids: biologic behavior and prognosis after differentiated treatment in relation to type.

Authors:  Kurt Borch; Bo Ahrén; Håkan Ahlman; Sture Falkmer; Göran Granérus; Lars Grimelius
Journal:  Ann Surg       Date:  2005-07       Impact factor: 12.969

5.  Oxyntic endocrine cells of hypergastrinaemic patients. Differential response to antrectomy or octreotide.

Authors:  T D'Adda; B Annibale; G Delle Fave; C Bordi
Journal:  Gut       Date:  1996-05       Impact factor: 23.059

6.  Argyrophil cell hyperplasia and a carcinoid tumour in the stomach of a patient with sporadic Zollinger-Ellison syndrome.

Authors:  G E Feurle
Journal:  Gut       Date:  1994-02       Impact factor: 23.059

Review 7.  Hyperplastic proliferations of the ECL cells.

Authors:  Y Dayal
Journal:  Yale J Biol Med       Date:  1992 Nov-Dec

Review 8.  Recognition and the histopathologic classification of ECL cell proliferations.

Authors:  Y Dayal
Journal:  Yale J Biol Med       Date:  1998 May-Aug

Review 9.  Pathobiology and management of hypergastrinemia and the Zollinger-Ellison syndrome.

Authors:  B I Hirschowitz
Journal:  Yale J Biol Med       Date:  1992 Nov-Dec

Review 10.  Praomys (Mastomys) natalensis: a model for gastric carcinoid formation.

Authors:  O Nilsson; B Wängberg; L Johansson; I M Modlin; H Ahlman
Journal:  Yale J Biol Med       Date:  1992 Nov-Dec
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.